Bartenschlager R, et al. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies. Virus Res. 2018;248:53–62.

Article  CAS  PubMed  Google Scholar 

Midgard H, et al. HCV epidemiology in high-risk groups and the risk of reinfection. J Hepatol. 2016;65(1):S33–45.

Article  PubMed  Google Scholar 

Stone J, et al. The potential impact of a hepatitis C vaccine for people who inject drugs: is a vaccine needed in the age of direct-acting antivirals? PLoS ONE. 2016;11(5):e0156213.

Article  PubMed  PubMed Central  Google Scholar 

Slagle BL, Bouchard MJ. Hepatitis B virus X and regulation of viral gene expression. Cold Spring Harbor Perspect Med. 2016;6(3):a021402.

Article  Google Scholar 

Tu T et al. Hepatitis B virus DNA integration occurs early in the viral life cycle in an. Vitro.

Kaufmann AM, et al. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res. 2002;8(12):3676–85.

CAS  PubMed  Google Scholar 

de Vos PJ, et al. A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions. Cancer Immunol Immunother. 2012;61:1485–92.

Article  Google Scholar 

Obeng-Adjei N, et al. DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. Cancer Gene Ther. 2013;20(12):652–62.

Article  CAS  PubMed  Google Scholar 

Godon O, et al. Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues. Mol Ther. 2014;22(3):675–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelly C et al. A therapeutic vaccine for HCV based on novel, rare, adenoviral vectors. 2011.

Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2018;16(8):1356.

Article  Google Scholar 

Le T, et al. mRNA vaccine development for emerging animal and zoonotic diseases. Viruses. 2022;14(2):401.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasamineh S, et al. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol. 2022;20(1):1–26.

Article  Google Scholar 

Karimkhanilouyi S, Ghorbian S. Nucleic acid vaccines for hepatitis B and C virus. Infect Genet Evol. 2019;75:103968.

Article  CAS  PubMed  Google Scholar 

Zhao H, et al. A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression. npj Vaccines. 2024;9(1):22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bender D, Glitscher M, Hildt E. Viral hepatitis A to E: prevalence, pathogen characteristics, and pathogenesis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;65(2):139–48.

Article  PubMed  PubMed Central  Google Scholar 

Walker CM. Adaptive immune responses in hepatitis a virus and hepatitis E virus infections. Cold Spring Harbor Perspect Med. 2019;9(9):a033472.

Article  CAS  Google Scholar 

Flefel EM, et al. Synthesis of some new pyridazine derivatives for anti-HAV evaluation. Molecules. 2017;22(1):148.

Article  PubMed  PubMed Central  Google Scholar 

Lin K-Y, et al. Hepatitis A virus infection and hepatitis a vaccination in human immunodeficiency virus-positive patients: a review. World J Gastroenterol. 2017;23(20):3589.

Article  PubMed  PubMed Central  Google Scholar 

Nelson NP. Update: recommendations of the Advisory Committee on Immunization Practices for use of hepatitis A vaccine for postexposure prophylaxis and for preexposure prophylaxis for international travel. MMWR. Morbidity and Mortality Weekly Report; 2018. p. 67.

Google Scholar 

Bordi L, et al. Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008–2009. J Clin Virol. 2012;54(1):26–9.

Article  PubMed  Google Scholar 

Vaughan G, et al. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014;21:227–43.

Article  PubMed  Google Scholar 

Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses. 2021;13(10):1900.

Article  PubMed  PubMed Central  Google Scholar 

Dudareva S, et al. Epidemiology of viral hepatitis A to E in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(2):149–58.

Article  PubMed  PubMed Central  Google Scholar 

D’Andrea L, et al. Hepatitis A virus genotype distribution during a decade of universal vaccination of preadolescents. Int J Mol Sci. 2015;16(4):6842–54.

Article  PubMed  PubMed Central  Google Scholar 

Torre P, et al. Viral hepatitis: milestones, unresolved issues, and future goals. World J Gastroenterol. 2021;27(28):4603.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lanford RE, Walker CM, Lemon SM. Nonhuman primate models of hepatitis a virus and hepatitis E virus infections. Volume 9. Cold Spring Harbor perspectives in medicine; 2019. p. a031815. 2.

Google Scholar 

Win NN, et al. Superinfection of Hepatitis A virus in hepatocytes infected with hepatitis B virus. Int J Med Sci. 2019;16(10):1366.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gotlieb N, Moradpour D, Shouval D. Hepatitis A and E–differences and commonalities. J Hepatol. 2020;72(3):578–80.

Article  PubMed  Google Scholar 

Nain A, Kumar M, Banerjee M. Oligomers of hepatitis a virus (HAV) capsid protein VP1 generated in a heterologous expression system. Microb Cell Fact. 2022;21(1):53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gholizadeh O, Akbarzadeh S. Hepatitis A: Viral Structure, Classification, Life Cycle, Clinical Symptoms, Diagnosis Error, and Vaccination. 2023. 2023: p. 4263309.

Van Damme P, et al. Hepatitis A virus infection. Nat Reviews Disease Primers. 2023;9(1):51.

Article  PubMed  Google Scholar 

Mahtab M-A, et al. Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis International: HBPD INT. 2008;7(5):457–64.

Google Scholar 

Nguyen CH, et al. Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam. J Med Virol. 2011;83(3):399–404.

Article  PubMed  Google Scholar 

Asami J, et al. Structural basis of hepatitis B virus receptor binding. Nat Struct Mol Biol. 2024;31(3):447–54.

Article  CAS  PubMed  Google Scholar 

Kim H, et al. Current progress in the development of hepatitis B virus capsid assembly modulators: chemical structure, mode-of-action and efficacy. Molecules. 2021;26(24):7420.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li D, Hamadalnil Y, Tu T. Hepatitis B viral protein HBx: roles in viral replication and Hepatocarcinogenesis. Viruses. 2024;16(9):1361.

Article  CAS  PubMed  PubMed Central  Google Scholar